Signaling networks in the pathophysiology and treatment of mood disorders

TD Gould, HK Manji - Journal of psychosomatic research, 2002 - Elsevier
Over the past decade, the focus of research into the pathophysiology of mood disorders
(bipolar disorder and unipolar depression in particular) has shifted from an interest in the …

Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders?

L Hertz, Y Chen, ME Gibbs, P Zang… - Current Drug Targets …, 2004 - ingentaconnect.com
Considerable attention has recently been paid to astrocyte functions, which are briefly
summarized. A large amount of data is available about adrenoceptor expression and …

Neurobiología de la depresión mayor y de su tratamiento farmacológico

H Cruzblanca Hernández, P Lupercio Coronel… - Salud mental, 2016 - scielo.org.mx
INTRODUCCIÓN: La depresión mayor (DM) se debe a la interacción de factores
ambientales, genéticos y epigenéticos, que atenúan la transmisión monoaminérgica en el …

G protein signaling and the molecular basis of antidepressant action

RJ Donati, MM Rasenick - Life sciences, 2003 - Elsevier
Over the past four decades, a variety of interventions have been used for the treatment of
clinical depression and other affective disorders. Several distinct pharmacological …

Long‐term treatment with fluoxetine induces desensitization of 5‐HT4 receptor‐dependent signalling and functionality in rat brain

R Vidal, EM Valdizán, R Mostany… - Journal of …, 2009 - Wiley Online Library
The mode of action of antidepressant drugs may be related to mechanisms of monoamines
receptor adaptation, including serotonin 5‐HT4 receptor subtypes. Here we investigated the …

The role of G-proteins and G-protein regulating proteins in depressive disorders

NB Senese, MM Rasenick, JR Traynor - Frontiers in Pharmacology, 2018 - frontiersin.org
Progress toward new antidepressant therapies has been relatively slow over the past few
decades, with the result that individuals suffering from depression often struggle to find an …

Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants

G Chen, KA Hasanat, JM Bebchuk… - Psychosomatic …, 1999 - journals.lww.com
Objective To determine whether the currently available evidence supports the hypothesis
that antidepressants and mood stabilizers may bring about some of their long-term …

Chronic antidepressant treatment prevents accumulation of Gsα in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts)

RJ Donati, MM Rasenick - Neuropsychopharmacology, 2005 - nature.com
Previous studies demonstrated that Gsα migrates from a Triton X-100 (TTX-100) insoluble
membrane domain to a TTX-100 soluble membrane domain in response to chronic …

Treatment of C6 Glioma Cells and Rats with Antidepressant Drugs Increases the Detergent Extraction of G from Plasma Membrane

S Toki, RJ Donati, MM Rasenick - Journal of neurochemistry, 1999 - Wiley Online Library
Results from previous studies suggested that chronic treatment of rats or C6 glioma cells
with antidepressants augments the coupling between Gs and adenylyl cyclase. As these …

Effects of lithium on receptor-mediated activation of G proteins in rat brain cortical membranes

HY Wang, E Friedman - Neuropharmacology, 1999 - Elsevier
The underlying molecular mechanism of action of lithium in the treatment of manic-
depressive illness is not clear. The effect of chronic lithium on GTP-binding and toxin …